Seeker Biologics aims to make new medicines for allergic, autoimmune and inflammatory diseases.
Seeker Biologics has raised $24.1M in total funding. The most recent round was Series A. The last funding was announced in September 2021.
Seeker Biologics is headquartered in Boston, United States.
Seeker Biologics aims to make new medicines for allergic, autoimmune and inflammatory diseases.
Seeker Biologics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seeker Biologics — Funding & Investors." VCBacked, September 30, 2021, https://www.vcbacked.co/company/seeker-biologics. Accessed October 1, 2026.
VCBacked. (2021). Seeker Biologics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/seeker-biologics
{{cite web |title=Seeker Biologics — Funding & Investors |url=https://www.vcbacked.co/company/seeker-biologics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated